However, subsequent studies revealed controversial results, and were unable to confirm the value of KIR4.1 antibodies for an MS diagnosis [41,42,43,44,45,46,47,48,49,50,51]. This evidence concerns the gene KCNJ10 and myeloid sarcoma.